anonymous
Guest
anonymous
Guest
And it begins, AAA NET will be cut and absorbed by AAA prostrate. What’s next? Lung/Breasts is CLEARLY over saturated. Good luck.
wrong
And it begins, AAA NET will be cut and absorbed by AAA prostrate. What’s next? Lung/Breasts is CLEARLY over saturated. Good luck.
No offense but the reality is the Aimovig reps experience vs. someone in Oncology isn't even close. You are talking about 200 people that got let go with minimal experience selling in complex (injectable, infusion) type environment.
And those reps were given very fair packages.
wrong
i'm making 190 base at aaa and doing nothing. we don't need cut. management is a bunch of morons
Who is this psychopath fixated on some dude who got a job over them? How many times can one post about this? Seriously, move onHow’s Mr Clean doing up in Detroit with his $193 in salary and no FDA approval. Time will tell about cuts to AAA.
How’s Mr Clean doing up in Detroit with his $193 in salary and no FDA approval. Time will tell about cuts to AAA.
Where are all you people coming up with this rhetoric? Oncology is the cash cow here and will be for a long time.
And it begins, AAA NET will be cut and absorbed by AAA prostrate. What’s next? Lung/Breasts is CLEARLY over saturated. Good luck.
This was posted in December 2021. Isn’t that interesting?
Rashema promised no changes before the end of the year so I’m guessing there will be an announcement in January to take effect on May 01, 2022.
Exactly! How can they not reduce the Hem/Onc salesforce size with limited office access? I believe this is the calm before the storm.